Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Time is Brain is a medical technology company dedicated to improving the prognosis of patients with acute ischemic stroke. The company has developed BraiNx, a first-in-class medical device that provides real-time monitoring of brain viability from the onset of stroke through the entire treatment process. By using non-invasive electrophysiological signals to measure N20-evoked potentials, the technology allows clinicians to track the effectiveness of reperfusion therapies and make faster, more informed decisions. This real-time feedback aims to reduce the time to treatment and minimize permanent brain damage. The company operates as a spin-off from the Hospital Universitari Germans Trias i Pujol in Barcelona.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Time is Brain.